Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcomes among patients with peripheral artery disease in the Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-Term Effectiveness (ADAPTABLE) study.
Weissler EH, Stebbins A, Wruck L, Muñoz D, Gupta K, Girotra S, Whittle J, Benziger CP, Polonsky TS, Bradley SM, Hammill BG, Merritt JG, Zemon DN, Hernandez AF, Jones WS. Weissler EH, et al. Among authors: benziger cp. Vasc Med. 2023 Apr;28(2):122-130. doi: 10.1177/1358863X231154951. Vasc Med. 2023. PMID: 37025023 Free PMC article. Clinical Trial.
Adapting a clinical decision support system to improve identification of pediatric hypertension in a rural health system: Design of a pragmatic trial.
Benziger CP, Suess M, Allen CI, Freitag LA, Asche SE, Ekstrom HL, Essien IJ, Muthineni A, Thirumalai V, Vo PH, Kromrey KA, Ronkainen EA, Saman DM, O'Connor PJ, Kharbanda EO. Benziger CP, et al. Contemp Clin Trials. 2023 Sep;132:107293. doi: 10.1016/j.cct.2023.107293. Epub 2023 Jul 16. Contemp Clin Trials. 2023. PMID: 37454727 Free PMC article.
Impact of aspirin dose according to race in secondary prevention of atherosclerotic cardiovascular disease: a secondary analysis of the ADAPTABLE randomised controlled trial.
Marquis-Gravel G, Mulder H, Wruck LM, Benziger CP, Effron MB, Farrehi PM, Girotra S, Gupta K, Kripalani S, Muñoz D, Polonsky TS, Whittle J, Harrington R, Rothman R, Hernandez AF, Jones WS. Marquis-Gravel G, et al. Among authors: benziger cp. BMJ Open. 2024 Aug 7;14(8):e078197. doi: 10.1136/bmjopen-2023-078197. BMJ Open. 2024. PMID: 39117415 Free PMC article. Clinical Trial.
Contribution of Clinical Trial Event Data by Data Source: A Prespecified Analysis of the ADAPTABLE Randomized Clinical Trial.
Rymer JA, Mulder H, Wruck LM, Muñoz D, Kripalani S, Effron MB, Gupta K, Handberg E, Jain S, Girotra S, Whittle J, Hess R, Benziger CP, Knowlton KU, Curtis LH, Roe MT, Hammill BG, Rothman RL, Harrington R, Hernandez A, Jones WS. Rymer JA, et al. Among authors: benziger cp. JAMA Cardiol. 2024 Sep 1;9(9):852-857. doi: 10.1001/jamacardio.2024.2019. JAMA Cardiol. 2024. PMID: 39046724 Clinical Trial.
Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Male and Female Patients: A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial.
Benziger CP, Stebbins A, Wruck LM, Effron MB, Marquis-Gravel G, Farrehi PM, Girotra S, Gupta K, Kripalani S, Munoz D, Polonsky TS, Sharlow A, Whittle J, Harrington RA, Rothman RL, Hernandez AF, Jones WS. Benziger CP, et al. JAMA Cardiol. 2024 Sep 1;9(9):808-816. doi: 10.1001/jamacardio.2024.1712. JAMA Cardiol. 2024. PMID: 38985488 Clinical Trial.
Angiographic characteristics of patients with STEMI and COVID-19: Insights from NACMI registry.
Dehghani P, Singh J, Mancini GBJ, Stanberry L, Bergstedt S, Madan M, Benziger CP, Ghasemzadeh N, Bortnick A, Kankaria R, Grines CL, Nayak K, Yildiz M, Alraies MC, Bagai A, Patel RAG, Amlani S, Case BC, Waksman R, Shavadia JS, Stone JH, Acharya D, Javed N, Bagur R, Garberich R, Garcia S, Henry TD. Dehghani P, et al. Among authors: benziger cp. Am Heart J. 2024 May;271:112-122. doi: 10.1016/j.ahj.2024.02.012. Epub 2024 Feb 22. Am Heart J. 2024. PMID: 38395293
Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular Disease.
Marquis-Gravel G, Stebbins A, Wruck LM, Roe MT, Effron MB, Hammill BG, Whittle J, VanWormer JJ, Robertson HR, Alikhaani JD, Kripalani S, Farrehi PM, Girotra S, Benziger CP, Polonsky TS, Merritt JG, Gupta K, McCormick TE 3rd, Knowlton KU, Jain SK, Kochar A, Rothman RL, Harrington RA, Hernandez AF, Jones WS. Marquis-Gravel G, et al. Among authors: benziger cp. J Am Heart Assoc. 2024 Feb 20;13(4):e026921. doi: 10.1161/JAHA.122.026921. Epub 2024 Feb 13. J Am Heart Assoc. 2024. PMID: 38348779 Free PMC article. Clinical Trial.
Global Burden of Cardiovascular Diseases and Risks, 1990-2022.
Mensah GA, Fuster V, Murray CJL, Roth GA; Global Burden of Cardiovascular Diseases and Risks Collaborators. Mensah GA, et al. J Am Coll Cardiol. 2023 Dec 19;82(25):2350-2473. doi: 10.1016/j.jacc.2023.11.007. J Am Coll Cardiol. 2023. PMID: 38092509 Free PMC article. No abstract available.
42 results